J2KBIO Co., Ltd. (KOSDAQ:420570)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Specialty Chemicals	28.47B	16.03B	-
Specialty Chemicals Growth	77.60%	-	-
Total	28.47B	16.03B	-
Total Growth	77.60%	-	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
South Korea	28.47B	16.03B	-
South Korea Growth	77.60%	-	-
Total	28.47B	16.03B	-
Total Growth	77.60%	-	-

Source: S&P Global Market Intelligence.